Default company panoramic image
Logo

HOCOR Cardiovascular Technologies

Our life-saving temporary heart valve catheter is 10 pigs away from FDA approval for human use.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Honolulu, HI, USA
  • Currency USD
  • Founded August 2007
  • Employees 1
  • Incorporation Type LLC
  • Website hocorcardiovascular.com

Company Summary

HOCOR’s temporary heart valve catheter that can save lives in an emergent situation. Our invention has been awarded 8 patents (7US, 1EU), and the technology has been validated in 8 medical journal publications. The FDA said in a letter that we have reached the last round of animal study of 10 pigs before human use. The cost of this final step is estimated to be $750,000.

Team

  • Default avatar
    Paul C. Ho
    President, CEO

    Founder of HOCOR and inventor of the HOCOR system, Dr. Ho practices Clinical and Interventional Cardiology in Honolulu, Hawaii and has performed over 5,000 percutaneous cardiac procedures. He has been involved in numerous clinical studies of cardiovascular devices. Trained as a Biomedical Engineer at the University of Pennsylvania, he received his Medicine and Cardiology training at the Dartmouth and Harvard Medical Schools.

Advisors

  • Default avatar
    Stewart Pressman, JD McCorriston Miller Mukai MacKinnon LLP
    Lawyer
    Unconfirmed
    Default avatar
    Alan Schlissel, JD, MBA KMH-LLP
    Accountant
    Unconfirmed